Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001730463-19-000013
Filing Date
2019-11-07
Accepted
2019-11-07 16:28:13
Documents
79
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 6-K autolus-20190930x6k.htm 6-K 27676
2 EXHIBIT 99.1 exhibit991-consolidatedfin.htm EX-99.1 771508
3 EXHIBIT 99.2 exhibit992-operatingresult.htm EX-99.2 235639
  Complete submission text file 0001730463-19-000013.txt   4964312

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT autl-20190930.xml EX-101.INS 812226
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20190930.xsd EX-101.SCH 45110
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT autl-20190930_cal.xml EX-101.CAL 75826
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20190930_def.xml EX-101.DEF 200547
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20190930_lab.xml EX-101.LAB 540841
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20190930_pre.xml EX-101.PRE 349051
Mailing Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ
Business Address FOREST HOUSE, 58 WOOD LANE WHITE CITY LONDON X0 W12 7RZ 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38547 | Film No.: 191200777
SIC: 2836 Biological Products, (No Diagnostic Substances)